Latest Communications

18 January 2012
APR Applied Pharma Research s.a. (“APR”), Labtec GmbH (“Labtec”) and Norgine BV (“Norgine”) announce the signature of an exclusive licensing agreement under which Norgine will market and distribute Setofilm™ Ondansetron Oral Dispersible Film (“ODF”), in Europe and selected non-European countries.

12 July 2011
MonoSol Rx Announces Availability of Zuplenz® Oral Soluble Film for Licensing to New Commercialization Partners

13 June 2011
APR Applied Pharma Research s.a. and Labtec GmbH announce Ondansetron Oral Dispersible Film (“ODF”) is now available for licensing in Europe and selected non European countries, after having received marketing authorization in most countries of Europe.


topical

Topical

APR has a long experience in topical pharmaceutical, medical device and dermo cosmetics formulations: a dynamic approach coupled with a solid background enables APR to offer the best and the most complete support starting from galenic phase to a complete Dossier ready for filling or Notification purpose.
APR has experience both on conventional and on modified release formulations and its galenic approach can range through different pharmaceutical forms such as gels, creams, ointments, spray, Hidro-gel and Matrix Patch.




Search results